16
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Subcellular Fractionation of Rectal Biopsy Homogenates from Patients with Inflammatory Bowel Disease

, , &
Pages 209-214 | Received 14 Jun 1983, Accepted 29 Oct 1984, Published online: 08 Jul 2009
 

Abstract

Rectal biopsy specimens from control subjects and from patients with Crohn's colitis. non-rectal Crohn's disease, and acute ulcerative colitis were homogenized in isotonic sucrose and subjected to analytical subcellular fractionation by sucrose density gradient centrifugation. The gradient fractions and tissue homogenates were assayed for marker enzymes for the principal organelles: 5′nucleotidase (plasma membrane). malate dehydrogenase (mitochondria), catalase (peroxisomes), lactate dehydrogenase (cytosol), N-acetyl-bT-glucosaminidase (lysosomes). and neutral-a-glu-cosidase (endoplasmic reticulum). In normal tissue there was a distinct plasma membrane peak at density 1.12 g/ml. In tissue from patients with Crohn's disease the activity was increased approximately twofold even when the rectum showed no evidence of histological involvement. A second plasma membrane component was noted in Crohn's disease at density 1.19 g/ml. The total activity of the mitochondrial enzyme was similar in the various patient groups, but there was evidence of mitochondrial damage. There were no significant alterations in activity and density gradient distributions of catalase or of neutral aL-glucosidase in the various patient groups, although less membrane-bound lactate dehydrogenase was noted in the patients with inflammatory bowel disease. There was a reduction of both cytosolic and particulate N-acetyl-bT-glucosaminidase in ulcerative colitis and a selective reduction in particulate activity in non-rectal Crohn's disease, demonstrating lysosomal alterations in these disorders. These results indicate selective and specific alterations in the principal subcellular organelles, especially the plasma membrane, lysosomes, and mitochondria, in the inflammatory bowel disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.